natgillin/translations-raw huggingface dataset:
When the white blood cell count is controlled, administer the maximum tolerated dose of IntronA (4 to 5 million IU/m2 daily) to maintain haematological remission.
Ko je število levkocitov pod nadzorom, dajte bolniku največji odmerek zdravila IntronA, ki ga še prenaša (4 do 5 milijonov i.e./m2 na dan), za ohranjanje hematološke remisije.
When there are 30 or more follicles in total it is advised to withhold hCG administration.
Če je vidnih skupaj 30 ali več foliklov, svetujemo, da ne uporabite hCG.
when there are any tumours in the area of the non-union site. if you are receiving chemotherapy, radiation treatment or immunosuppression
če so v bližini mesta nezraslega zloma tumorji; če prejemate kemo-, radio- ali imunosupresivno terapijo.
When there has been no hormonal contraceptive use in the preceding cycle
Če ženska v prejšnjem ciklu ni uporabljala hormonskega kontraceptiva
When there is a marked drop in fibrinogen or AntithrombinIII (ATIII) deficiency, consider targeted substitution (e.g. fresh frozen plasma).
V primeru izrazitega upada ravni fibrinogena ali pomanjkanja antitrombina III (ATIII) moramo razmisliti o nadomeščanju (npr. sveža zamrznjena plazma).
When these currents are blocked, the heart rate is lowered, so that the heart has less work to do and needs less oxygenated blood.
Ko so ti tokovi zavrti, se srčni utrip zniža, zato ima srce manj dela in potrebuje manj krvi s kisikom.
when these medicines are
PREZISTA je priporočljivo
When these receptors are activated, the breakdown of fats speeds up, which helps clear the blood of ‘bad’ cholesterol and triglycerides.
Aktiviranje teh receptorjev pospeši razgradnjo maščob, kar pomaga pri odstranjevanju „slabega“ holesterola in trigliceridov iz krvi.
When these signs occur, Zerit should be stopped and your HIV treatment changed.
Če se ti znaki pojavijo, je treba prekiniti zdravljenje z zdravilom ZERIT ter spremeniti vaše zdravljenje okužbe z virusom HIV.
When these signs or symptoms (signs or symptoms of anaphylactic reaction) occur they usually develop quickly after the injection is given and while the child is still in the clinic or doctor’s surgery.
Če se pojavijo ti znaki ali simptomi (znaki ali simptomi anafilaktične reakcije), se običajno razvijejo hitro po prejeti injekciji, ko je otrok še vedno v bolnišnici ali v zdravnikovi ambulanti.
When these signs or symptoms occur they usually develop quickly after the injection is given and while the child is still in the clinic or doctor’s surgery.
Če se pojavijo ti znaki ali simptomi, se običajno razvijejo hitro po prejeti injekciji, ko je otrok še vedno v zdravstvenem domu ali v zdravnikovi ambulanti.
when they are short, because they were born small for their gestational age, and have not caught up by the age of four years or later, when they have a genetic condition called Prader-Willi syndrome.
če so premajhne rasti, ker so se rodili majhni za svojo gestacijsko starost, in do starosti 4 let ali več niso nadomestili zaostanka; če imajo genetsko stanje, imenovano Prader-Willijev sindrom.
When this antigen is injected, this small exposure helps the pig’s immune system to recognise and attack CSF.
Po injiciranju tega antigena, ta majhna izpostavitev pripomore k temu, da imunski sistem prašiča prepozna in napade KPK.
When this happens in the joints and causes pain, it is known as ‘gout’.
Kadar pride do odlaganja v sklepih, ki povzroča bolečino, to imenujemo „protin“ ali „putika“.
When this happens, it is called ‘response’.
Pojav takega stanja se imenuje "odziv".
When this happens, the vaginal walls can become thinner.
Posledica je tanjšanje nožničnih sten.
When this medicine is taken with food, it may take a little longer for Sildenafil ratiopharm to work.
Če to zdravilo vzamete skupaj s hrano, bo morda trajalo malo dlje, da bo zdravilo Sildenafil ratiopharm začelo učinkovati.
When this results in a daily dose less than 14 mg/kg body weight, the patient’s response must be monitored and a dose increase should be considered if sufficient efficacy is not obtained (see section 5.1).
Če to pomeni dnevni odmerek, ki bi bil nižji od 14 mg/kg telesne mase, je treba spremljati bolnikov odziv in v primerih, ko ne pride do zadostne učinkovitosti, razmisliti o zvišanju odmerka (glejte poglavje 5.1).
When this results in a daily dose less than 20 mg/kg body weight, the patient’s response must be monitored and a dose increase should be considered if sufficient efficacy is not obtained (see section 5.1).
Če to pomeni dnevni odmerek, ki bi bil nižji od 20 mg/kg telesne mase, je treba spremljati bolnikov odziv in v primerih, ko ne pride do zadostne učinkovitosti, razmisliti o zvišanju odmerka (glejte poglavje 5.1).
When this treatment is finished, the infusion may go back to 0.25 mg/kg body weight per hour for an additional 4 to 12 hours.
Ko bo to zdravljenje končano, se bo odmerek za infundiranje zmanjšal nazaj na 0,25 mg/kg telesne mase na uro za dodatnih 4–12 ur.
When to apply the patch:
Kdaj namestiti obliž:
When to call an ambulance
Kdaj je treba poklicati rešilca
when to check your blood sugar level how to adjust the dose.
kdaj morate preveriti koncentracijo krvnega sladkorja, kako prilagoditi odmerek.
When to have someone to help you
Kdaj naj vam nekdo pomaga
When to inhale Enurev Breezhaler
Kdaj je treba inhalirati zdravilo Enurev Breezhaler
When to inhale Seebri Breezhaler
Kdaj je treba inhalirati zdravilo Seebri Breezhaler
When to inhale Tovanor Breezhaler
Kdaj je treba inhalirati zdravilo Tovanor Breezhaler
When to inhale Ultibro Breezhaler
Kdaj je treba inhalirati zdravilo Ultibro Breezhaler
When to inhale Ulunar Breezhaler
Kdaj je treba inhalirati zdravilo Ulunar Breezhaler
When to inhale Xoterna Breezhaler
Kdaj je treba inhalirati zdravilo Xoterna Breezhaler
When to inject your next dose:
Kdaj si je treba injicirati naslednji odmerek:
When to seek urgent attention from the health care provider
Kdaj poiskati nujno medicinsko pomoč.
When to seek urgent attention from the health care provider
Kdaj poiskati nujno zdravstveno pomoč
When to start using a new Aerivio Spiromax
Kdaj morate začeti uporabljati novo zdravilo Airexar Spiromax
When to take
Kdaj vzeti zdravilo Votrient
When to take it
Kdaj vzeti zdravilo Revolade
When to take Kalydeco 75 mg granules in sachet
Kdaj vzeti Kalydeco 75 mg zrnca v vrečici
When to take special care with EVRA
Kdaj morate posebno pozorni pri uporabi obliža EVRA
When to take special care with IOA
Kdaj morate biti posebej pozorni pri jemanju zdravila IOA
When to take Starlix
Kdaj jemljite zdravilo Starlix
When to take Trazec
Kdaj jemljite Trazec
When to use this medicine
Kdaj uporabiti to zdravilo
When topotecan (0.75 mg/m2/day for 5 consecutive days) and cisplatin (60 mg/m2/day on Day 1) were administered in 13 patients with ovarian cancer, a slight increase in AUC (12 %, n=9) and Cmax (23 %, n=11) was noted on day 5.
Pri dajanju topotekana (0,75 mg/m2/dan 5 zaporednih dni) in cisplatina (60 mg/m2/dan na 1. dan) 13 bolnicam z rakom jajčnika so 5. dan opazili rahlo povečanje vrednosti AUC (12 %, n = 9) in Cmax (23 %, n = 11).
When topotecan (0.75 mg/m2/day for 5 consecutive days) and cisplatin (60 mg/m2/day on Day 1) were administered in 13 patients with ovarian cancer, a slight increase in AUC (12 %, n=9) and Cmax (23 %, n=11) was noted on day 5.
Pri dajanju topotekana (0,75 mg/m2/dan pet zaporednih dni) in cisplatina (60 mg/m2/dan na 1. dan) 13 bolnicam z rakom jajčnika so 5. dan opazili rahlo povečanje vrednosti AUC (12 %, n = 9) in Cmax (23 %, n = 11).
When topotecan (0.75 mg/m2/day for five consecutive days) and cisplatin (60 mg/m2/day on Day 1) were administered in 13 patients with ovarian cancer, a slight increase in AUC (12 %, n = 9) and Cmax (23 %, n = 11) was noted on day 5.
Pri dajanju topotekana (0,75 mg/m2/dan 5 zaporednih dni) in cisplatina (60 mg/m2/dan na 1. dan) 13 bolnicam z rakom jajčnika so 5. dan opazili rahlo povečanje vrednosti AUC (12 %, n = 9) in Cmax (23 %, n = 11).
When topotecan (0.75 mg/m2day for 5 consecutive days) and cisplatin (60 mg/m2/day on Day 1) were administered in 13 patients with ovarian cancer, a slight increase in AUC (12%, n=9) and Cmax (23%, n=11) was noted on day 5.
Pri dajanju topotekana (v odmerku 0,75 mg/m2 na dan 5 zaporednih dni) in cisplatina (v odmerku 60 mg/m2 na dan prvi dan) 13 bolnicam z rakom jajčnikov so 5. dan opazili rahlo povečanje vrednosti AUC (12 %, n = 9) in Cmax (23 %, n = 11).
When toxicity resolves re-initiate Bortezomib Hospira treatment and reduce dose to 0.7 mg/m2 once per week.
Nato ponovno uvedite zdravljenje z zdravilom Bortezomib Hospira in zmanjšajte odmerek na 0,7 mg/m2 enkrat na teden.
When toxicity resolves re-initiate VELCADE treatment and reduce dose to 0.7 mg/m2 once per week.
Nato ponovno uvedite zdravljenje z zdravilom VELCADE in zmanjšajte odmerek na 0,7 mg/m2 enkrat na teden.
When trametinib is given in combination with dabrafenib, the SmPC of dabrafenib must be consulted prior to intiation of treatment.
Pri dajanju trametiniba v kombinaciji z dabrafenibom je treba pred začetkom zdravljenja pregledati povzetek glavnih značilnosti zdravila za dabrafenib.
When trametinib is used in combination with dabrafenib and the patient’s temperature is ≥38.5oC please refer to the dabrafenib SmPC (section 4.2) for dose modifications for dabrafenib.
Kadar je pri uporabi trametiniba v kombinaciji z dabrafenibom bolnikova telesna temperatura 38,5 oC ali več, za prilagoditev odmerka dabrafeniba glejte povzetek glavnih značilnosti zdravila za dabrafenib (poglavje 4.2).
When trametinib is used in combination with dabrafenib and the patient’s temperature is ≥38.5oC please refer to the dabrafenib SmPC (section 4.2) for dose modifications for dabrafenib.
Kadar je pri uporabi trametiniba v kombinaciji z dabrafenibom bolnikova telesna temperatura 38,5 oC ali več, za spreminjanje odmerka dabrafeniba glejte povzetek glavnih značilnosti zdravila za dabrafenib (poglavje 4.2).
When transition between different antiepileptic therapies is medically required, this should be done gradually and with appropriate clinical supervision.
Kadar je prehod med različnimi antiepileptičnimi terapijami medicinsko potreben, ga je treba izvesti postopoma in ob ustreznem zdravniškem nadzoru.
When treating cervical cancer, Hycamtin is combined with another drug called cisplatin.
Pri zdravljenju raka materničnega vratu zdravilo Hycamtin uporabljamo skupaj z drugim zdravilom, ki vsebuje cisplatin.
When treating cervical cancer, Hycamtin is combined with another medicine, called cisplatin.
Pri zdravljenju raka materničnega vratu se zdravilo Hycamtin uporablja skupaj z drugim zdravilom, ki vsebuje cisplatin.
When treating cervical cancer, Topotecan Hospira is combined with another medicine called cisplatin.
Pri zdravljenju raka materničnega vratu uporabljamo zdravilo Topotecan Hospira z drugim zdravilom, ki mu pravimo cisplatin.
When treating cervical cancer, topotecan will be given to you with another medicine, called cisplatin.
Pri zdravljenju raka materničnega vratu boste topotekan prejemali z drugim zdravilom, ki mu pravimo cisplatin.
When treating HIV infection it is not always possible to differentiate between unwanted effects caused by Zerit or those caused by any other medicines you may be taking at the same time, or by the complications of the infection.
Pri zdravljenju okužbe s HIV ni vedno mogoče razlikovati med neželenimi učinki, ki jih povzroči zdravilo Zerit, ter med neželenimi učinki drugih zdravil, ki jih morda jemljete hkrati, in zapleti same okužbe.
When treating HIV infection, it is not always possible to tell whether some of the unwanted effects are caused by Vitekta or by other medicines that you are taking at the same time, or by the HIV infection itself.
Pri zdravljenju okužbe z virusom HIV ni vedno mogoče povedati, ali nekatere od naštetih neželenih učinkov povzroča zdravilo Vitekta ali druga zdravila, ki jih jemljete sočasno, ali sama okužba s HIV.
When treating infections caused by Brachyspira spp., therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria.
Pri zdravljenju okužb, ki jih povzroča Brachyspira spp., mora zdravljenje temeljiti na lokalnih epidemioloških informacijah (regionalnih ali na ravni kmetije) o odpornosti ciljne bakterije.
When treating infections caused by known or suspected beta-lactam and/or macrolide resistant strains (according to history of patients or national and/or regional resistance data) covered by the antibacterial spectrum of telithromycin (see sections 4.4 and 5.1):
Zdravljenje okužb, ki so jih ali bi jih lahko povzročili sevi, odporni proti betalaktamskim ali makrolidnim antibiotikom ali obojim (glede na anamnezo bolnika ali nacionalne in/ali regionalne podatke o odpornosti), ki jih pokriva protibakterijski spekter telitromicina (glejte poglavji 4.4 in 5.1):
When treating pruritus associated with allergic dermatitis with oclacitinib, investigate and treat any underlying causes (e.g. flea allergic dermatitis, contact dermatitis, food hypersensitivity).
Pri uporabi oklacitiniba za zdravljenja pruritusa, povezanega z alergičnim dermatitisom, odkrijte in zdravite primarno bolezen (npr. alergijski dermatitis, ki ga povzročijo bolhe, kontaktni dermatitis, intoleranca na hrano).
When treating pruritus associated with allergic dermatitis with oclacitinib, investigate and treat any underlying causes (e.g., flea allergic dermatitis, contact dermatitis, food hypersensitivity).
Pri uporabi oklacitiniba za zdravljenja pruritusa, povezanega z alergičnim dermatitisom, odkrijte in zdravite primarno bolezen (npr. alergijski dermatitis, ki ga povzročijo bolhe, kontaktni dermatitis, intoleranca na hrano).
When treatment is given at home, support from another responsible person should be available for treating adverse reactions or to summon help should a serious adverse reaction occur.
Če se zdravljenje izvaja doma, mora biti na voljo druga odgovorna oseba za zdravljenje neželenih reakcij ali klicanje pomoči, če bi prišlo do hudega neželenega učinka.
When treatment starts, Retacrit is usually injected by medical or nursing staff.
Na začetku zdravljenja zdravilo Retacrit običajno injicirajo medicinske sestre ali zdravnik.
When treatment was continued for more than 26 weeks, six additional patients achieved and maintained Complete TMA response due to a decrease in serum creatinine.
Ko so zdravljenje nadaljevali po 26. tednu, je še šest dodatnih bolnikov doseglo in vzdrževalo popoln TMA odgovor zaradi znižanja serumskega kreatinina..
when treatment with docetaxel (a cancer medicine) has not worked or no longer works. when hormone therapy has not worked, and the patient has either no symptoms or mild symptoms and does not require chemotherapy (another type of cancer treatment).
ko zdravilo docetaksel (zdravilo proti raku) ni bilo učinkovito ali ni več učinkovito, ko je bilo zdravljenje s hormoni neučinkovito, bolnik pa nima simptomov ali so simptomi blagi ter ne zahtevajo kemoterapije (drugi način zdravljenja raka).
When treatment with STAYVEER is initiated in patients who require ritonavir-boosted protease inhibitors, the patient’s tolerability of STAYVEER should be closely monitored with special attention, at the beginning of the initiation phase, to the risk of hypotension and to liver function tests.
Ko se zdravljenje z zdravilom STAYVEER uvede pri bolnikih, ki potrebujejo zaviralce proteaze, pospešene z ritonavirjem, je treba prenašanje zdravila STAYVEER pri teh bolnikih skrbno nadzirati s posebno pozornostjo na začetku faze uvajanja v zvezi s tveganjem hipotenzije in preiskavami delovanja jeter.
When treatment with Tracleer is initiated in patients who require ritonavir-boosted protease inhibitors, the patient’s tolerability of Tracleer should be closely monitored with special attention, at the beginning of the initiation phase, to the risk of hypotension and to liver function tests.
Ko se zdravljenje z zdravilom Tracleer uvede pri bolnikih, ki potrebujejo zaviralce proteaze, pospešene z ritonavirjem, je treba prenašanje zdravila Tracleer pri teh bolnikih skrbno nadzirati s posebno pozornostjo na začetku faze uvajanja v zvezi s tveganjem hipotenzije in preiskavami delovanja jeter.
When treatment with Tracleer is initiated in patients who require ritonavir-boosted protease inhibitors, the patient’s tolerability of Tracleer should be closely monitored with special attention, at the beginning of the initiation phase, to the risk of hypotension and to liver function tests.
Ko se zdravljenje z zdravilom Tracleer uvede pri bolnikih, ki potrebujejo zaviralce proteaze, pospešene zritonavirjem, je treba prenašanje zdravila Tracleer pri teh bolnikih skrbno nadzirati s posebno pozornostjo na začetku faze uvajanja v zvezi s tveganjem hipotenzije in preiskavami delovanja jeter.
When turning the dose selector be careful not to push the push- button as insulin will come out.
Med vrtenjem izbirnika odmerka pazite, da ne boste pritisnili na potisni gumb, ker bi s tem iztisnili insulin.
When turning the dose selector be careful not to push the push- button as insulin will come out.
Med vrtenjem izbirnika odmerka pazite, da ne pritisnete na potisni gumb, ker bi s tem iztisnili insulin.
When turning the dose selector, be careful not to push the push- button as insulin will come out.
Med vrtenjem izbirnika odmerka pazite, da ne pritisnete na potisni gumb, ker bi s tem iztisnili insulin.
When turning the dose selector, be careful not to push the push– button as insulin will come out.
Med vrtenjem izbirnika odmerka pazite, da ne pritisnete na potisni gumb, ker bi s tem iztisnili insulin.
When two types of insulin are mixed, draw the amount of fast-acting insulin first, followed by the amount of long-acting insulin.
V primeru mešanja dveh vrst insulinov je najprej treba izvleci odmerek hitrodelujocega insulina in potem odmerek dolgodelujocega insulina.
When ultrasound assessment indicates the presence of at least three follicles of 16-20 mm, and there is evidence of a good oestradiol response (plasma levels of about 300-400 picograms/mL (1,000-1,300 pmol/L) for each follicle with a diameter greater than 18 mm), the final phase of maturation of the follicles is induced by administration of hCG.
Če ultrazvočna preiskava pokaže najmanj tri prisotne folikle s premerom 16 do 20 mm, in če se tudi vrednosti estradiola ustrezno povečajo (plazemske koncentracije približno 300 do 400 pikogramov/ml (1.000 do 1.300 pmol/l) za vsak folikel s premerom večjim od 18 mm), sprožite končno fazo zorenja folikla s hCG.
When umeclidinium bromide is inhaled, it also causes the muscles of the airways to relax.
Ob inhalaciji umeklidinijev bromid sprosti mišice v dihalih.
When umeclidinium bromide is inhaled, it causes the muscles of the airways to relax, helping to keep the airways open and allowing the patient to breathe more easily.
Po vdihu umeklidinijevega bromida se mišice dihalnih poti sprostijo, kar pomaga ohranjati dihalne poti prehodne in omogoča bolniku, da lažje diha.
When umeclidinium is inhaled, it also causes the muscles of the airways to relax.
Ob vdihu umeklidinija se mišice dihalnih poti prav tako sprostijo.
When under-delivery is caused by a problem with the pump, a rinse procedure should be performed.
Če je vzrok nezadostnega dovajanja insulina črpalka, je treba opraviti izpiranje črpalke.
When under-delivery of insulin is due to catheter occlusion, the side port catheter may be flushed with 5-10 ml of sterile rinse buffer solution.
Če je vzrok nezadostnega dovajanja insulina zapora katetra, je mogoče kateter s stranskim nastavkom izprati s 5 do 10 ml sterilne puferske raztopine za izpiranje.
When undergoing assisted reproductive technology or stimulation of your ovaries to produce eggs, you are more likely to have a miscarriage than the average woman.
Pri postopkih asistirane reprodukcije ali stimulacije jajčnikov za tvorbo jajčec je verjetnost splava večja kot pri povprečnih ženskah.
When undergoing assisted reproductive technology the risk of having a multiple pregnancy is related to your age, the quality and number of fertilised eggs or embryos placed inside you.
Pri uporabi tehnik asistirane reprodukcije je tveganje za večplodno nosečnost povezano z vašo starostjo in kakovostjo ter številom oplojenih prenesenih jajčec ali embrijev.
When undergoing assisted reproductive technology the risk of having a multiple pregnancy is related your age, the quality and to the number of fertilised eggs or embryos placed inside you.
Pri uporabi tehnik asistirane reprodukcije je tveganje za večplodno nosečnost povezano z vašo starostjo in kakovostjo ter številom oplojenih prenesenih jajčec ali embrijev.
When Unituxin attaches to the GD2 on the cancer cells, the patient’s immune system starts to attack these cells and kill them.
Ko se zdravilo Unituxin pritrdi na GD2 rakastih celic, začne imunski sistem bolnika napadati te celice in jih pobije.
When urinary free/serum/ plasma cortisol levels are normalised or close to target and the effective dose of Ketoconazole HRA is established, monitoring can be undertaken every 3 to 6 months (see section 4.2 for dose adjustment in case of adrenal insufficiency).
Ko se ravni prostega kortizola v urinu/kortizola v serumu/plazmi normalizirajo ali se približajo ciljni vrednosti in se vzpostavi učinkoviti odmerek zdravila Ketokonazol HRA, se lahko spremljanje opravlja vsake 3 do 6 mesecev (za prilagajanje odmerka v primeru adrenalne insuficience glejte poglavje 4.2).
When used alone or in combination with other anti-diabetes medicines, Vipidia reduced HbA1c levels by 0.48–0.61% more than placebo.
Kadar se je zdravilo Vipidia uporabljalo kot samostojno zdravilo ali v kombinaciji z drugimi zdravili za zdravljenje sladkorne bolezni, so se ravni HbA1c zmanjšale za 0,48– 0,61 % bolj kot pri jemanju placeba.
When used as add-on combination therapy with metformin plus sulphonylurea, the overall incidence of reported hypoglycemia was 10.1% for Onglyza 5 mg and 6.3% for placebo.
Če je bilo zdravilo uporabljeno kot dodatek kombiniranemu zdravljenju z metforminom in sulfonilsečnino, je bila celotna incidenca opisanih hipoglikemij 10,1 % z zdravilom Onglyza 5 mg in 6,3 % s placebom.
When used as add-on to metformin plus a sulphonylurea, the overall incidence of reported hypoglycemia was 10.1% for saxagliptin 5 mg and 6.3% for placebo.
Če je bilo zdravilo uporabljeno kot dodatek metforminu v kombinaciji s sulfonilsečnino, je bila celotna incidenca opisanih hipoglikemij 10,1 % s 5 mg saksagliptina in 6,3 % s placebom.
When used as an add-on to levodopa, 1 mg Azilect reduced the time in the ‘off’ state more than placebo did.
Zdravilo Azilect 1 mg, uporabljeno kot dodatek levodopi, je skrajšalo čas stanja „off“ bolj kot placebo.
When used as an aid in reducing the development of clinical signs and mortality (where infection in ovum with Mycoplasma gallisepticum is likely):
Kadar se uporablja kot pomoč pri za zmanjševanju razvoja kliničnih znakov in smrtnosti (kjer je verjetna infekcija in ovo z Mycoplasma gallisepticum):
When used concomitantly with strong CYP3A4 inhibitors the dose should be reduced to 200 mg (see section 4.5).
Med sočasno uporabo močnih zaviralcev CYP3A4 je treba odmerek zmanjšati na 200 mg (glejte poglavje 4.5).
When used for angina, treatment should be stopped if there is no improvement in symptoms after 3 months and the doctor should consider stopping treatment if the improvement in symptoms or the reduction in the heart rate is only limited.
Pri angini pektoris je treba zdravljenje prekiniti, če po treh mesecih ne pride do izboljšanja simptomov, prav tako pa mora zdravnik razmisliti o prekinitvi zdravljenja, kadar je izboljšanje simptomov ali zmanjšanje srčnega utripa zgolj omejeno.
When used for asthma, your doctor will prescribe BiResp Spiromax together with a separate ‘reliever inhaler’ such as salbutamol.
Za zdravljenje astme vam bo zdravnik predpisal inhalator BiResp Spiromax skupaj z ločenim inhalatorjem z olajševalcem, npr. salbutamolom.
When used for asthma, your doctor will prescribe Budesonide/Formoterol Teva together with a separate ‘reliever inhaler’ such as salbutamol.
Za zdravljenje astme vam bo zdravnik predpisal inhalator Budezonid/formoterol Teva skupaj z ločenim inhalatorjem z olajševalcem, npr. salbutamolom.